134 related articles for article (PubMed ID: 17003007)
21. Work-up and management of paediatric Cushing's syndrome.
Savage MO; Chan LF; Grossman AB; Storr HL
Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):346-51. PubMed ID: 18594275
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome.
Leal-Cerro A; Pumar A; Garcia-Garcia E; Dieguez C; Casanueva FF
Clin Endocrinol (Oxf); 1994 Nov; 41(5):649-54. PubMed ID: 7828354
[TBL] [Abstract][Full Text] [Related]
23. Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome.
Tzanela M; Karavitaki N; Stylianidou C; Tsagarakis S; Thalassinos NC
Clin Endocrinol (Oxf); 2004 Mar; 60(3):309-14. PubMed ID: 15008995
[TBL] [Abstract][Full Text] [Related]
24. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
[TBL] [Abstract][Full Text] [Related]
25. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary restriction in patients with Cushing's syndrome.
Leal-Cerro A; Venegas E; Garcia-Pesquera F; Jimenez LM; Astorga R; Casanueva FF; Dieguez C
Clin Endocrinol (Oxf); 1998 Jan; 48(1):117-21. PubMed ID: 9509077
[TBL] [Abstract][Full Text] [Related]
26. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
[TBL] [Abstract][Full Text] [Related]
28. Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing's syndrome.
Weber A; Trainer PJ; Grossman AB; Afshar F; Medbak S; Perry LA; Plowman PN; Rees LH; Besser GM; Savage MO
Clin Endocrinol (Oxf); 1995 Jul; 43(1):19-28. PubMed ID: 7641408
[TBL] [Abstract][Full Text] [Related]
29. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
Huang YH; Wai YY; Van YH; Lo FS
J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcomes of children treated for Cushing's disease: a single center experience.
Yordanova G; Martin L; Afshar F; Sabin I; Alusi G; Plowman NP; Riddoch F; Evanson J; Matson M; Grossman AB; Akker SA; Monson JP; Drake WM; Savage MO; Storr HL
Pituitary; 2016 Dec; 19(6):612-624. PubMed ID: 27678103
[TBL] [Abstract][Full Text] [Related]
31. Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?
Cianfarani S; Tondinelli T; Spadoni GL; Scirè G; Boemi S; Boscherini B
Clin Endocrinol (Oxf); 2002 Aug; 57(2):161-7. PubMed ID: 12153594
[TBL] [Abstract][Full Text] [Related]
32. Effect of galanin on the growth hormone (GH) response to GH-releasing hormone in patients with Cushing's disease.
Giustina A; Bossoni S; Bussi AR; Pozzi A; Wehrenberg WB
Endocr Res; 1993 Mar; 19(1):47-56. PubMed ID: 7681769
[TBL] [Abstract][Full Text] [Related]
33. Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood?
Léger J; Danner S; Simon D; Garel C; Czernichow P
J Clin Endocrinol Metab; 2005 Feb; 90(2):650-6. PubMed ID: 15546901
[TBL] [Abstract][Full Text] [Related]
34. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
[TBL] [Abstract][Full Text] [Related]
35. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
Flitsch J; Knappe UJ; Lüdecke DK
Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
[TBL] [Abstract][Full Text] [Related]
36. The role of bilateral adrenalectomy in the treatment of refractory Cushing's disease.
Wong A; Eloy JA; Liu JK
Neurosurg Focus; 2015 Feb; 38(2):E9. PubMed ID: 25639327
[TBL] [Abstract][Full Text] [Related]
37. Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up.
Bakiri F; Tatai S; Aouali R; Semrouni M; Derome P; Chitour F; Benmiloud M
J Endocrinol Invest; 1996 Oct; 19(9):572-80. PubMed ID: 8957739
[TBL] [Abstract][Full Text] [Related]
38. The advantage of measuring spontaneous growth hormone (GH) secretion compared with the insulin tolerance test in the diagnosis of GH deficiency in young adults.
Radetti G; di Iorgi N; Paganini C; Gastaldi R; Napoli F; Lorini R; Maghnie M
Clin Endocrinol (Oxf); 2007 Jul; 67(1):78-84. PubMed ID: 17466007
[TBL] [Abstract][Full Text] [Related]
39. Pyridostigmine enhances even if it does not normalize the growth hormone responses to growth hormone-releasing hormone in patients with Cushing's disease.
Giustina A; Bossoni S; Bodini C; Ferrari C; Pizzocolo G; Scalvini T; Schettino M; Wehrenberg WB
Horm Res; 1991; 35(3-4):99-103. PubMed ID: 1806475
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
Korpal-Szczyrska M; Dorant B; Kamińska H; Birkholz D; Niedźwiecki M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):31-4. PubMed ID: 16704859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
